Yoko Oshima

692 total citations
60 papers, 485 citations indexed

About

Yoko Oshima is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yoko Oshima has authored 60 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 27 papers in Pulmonary and Respiratory Medicine and 22 papers in Oncology. Recurrent topics in Yoko Oshima's work include Gastric Cancer Management and Outcomes (20 papers), Esophageal Cancer Research and Treatment (13 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Yoko Oshima is often cited by papers focused on Gastric Cancer Management and Outcomes (20 papers), Esophageal Cancer Research and Treatment (13 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Yoko Oshima collaborates with scholars based in Japan, Australia and China. Yoko Oshima's co-authors include Hideaki Shimada, Satoshi Yajima, Tatsuki Nanami, Takashi Suzuki, Kimihiko Funahashi, Fumiaki Shiratori, Masaaki Ito, Hironori Kaneko, Kazuyuki Matsushita and Masatoshi Tagawa and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Surgery and Cancer Science.

In The Last Decade

Yoko Oshima

51 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoko Oshima Japan 13 237 166 152 128 120 60 485
Carla M. van Herpen Netherlands 14 325 1.4× 98 0.6× 146 1.0× 195 1.5× 113 0.9× 27 608
Yu Sawada Japan 13 363 1.5× 232 1.4× 122 0.8× 90 0.7× 109 0.9× 29 631
D. Paraïso France 14 272 1.1× 216 1.3× 96 0.6× 149 1.2× 54 0.5× 35 689
Daichi Nomoto Japan 12 247 1.0× 239 1.4× 165 1.1× 176 1.4× 90 0.8× 24 520
Olena Kolesnik Ukraine 5 249 1.1× 164 1.0× 79 0.5× 86 0.7× 143 1.2× 13 499
Vittorio Branchi Germany 15 277 1.2× 274 1.7× 188 1.2× 200 1.6× 162 1.4× 41 685
Nergiz Dağoğlu Türkiye 11 244 1.0× 170 1.0× 183 1.2× 67 0.5× 67 0.6× 35 440
Ricardo Sáinz de la Cuesta Spain 12 114 0.5× 125 0.8× 79 0.5× 181 1.4× 100 0.8× 23 831
An‐Cheng Shiau Taiwan 15 147 0.6× 103 0.6× 162 1.1× 63 0.5× 93 0.8× 41 539
Eric R. Manusama Netherlands 12 266 1.1× 88 0.5× 153 1.0× 162 1.3× 81 0.7× 14 546

Countries citing papers authored by Yoko Oshima

Since Specialization
Citations

This map shows the geographic impact of Yoko Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Oshima more than expected).

Fields of papers citing papers by Yoko Oshima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoko Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Oshima. The network helps show where Yoko Oshima may publish in the future.

Co-authorship network of co-authors of Yoko Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Yoko Oshima. A scholar is included among the top collaborators of Yoko Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoko Oshima. Yoko Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kikuchi, Yoshinori, Hideaki Shimada, Yutaka Hatanaka, et al.. (2023). Clinical practice guidelines for molecular tumor markers, 2nd edition review part 1. International Journal of Clinical Oncology. 29(1). 1–19. 2 indexed citations
2.
Oshima, Yoko, Tatsuki Nanami, Takashi Suzuki, et al.. (2021). Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer. Surgery Today. 51(10). 1638–1648. 21 indexed citations
3.
Nanami, Tatsuki, Isamu Hoshino, Fumiaki Shiratori, et al.. (2021). Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers. International Journal of Clinical Oncology. 27(1). 72–76. 6 indexed citations
4.
Ito, Masaaki, Takaki Hiwasa, Yoko Oshima, et al.. (2021). Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer. Frontiers in Oncology. 11. 708039–708039. 15 indexed citations
5.
Suzuki, Takashi, Satoshi Yajima, Yoko Oshima, et al.. (2021). Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma. Esophagus. 19(1). 105–112. 9 indexed citations
6.
Koda, Naoya, Yoko Oshima, Keiji Koda, & Hideaki Shimada. (2020). Surgeon fatigue does not affect surgical outcomes: a systematic review and meta-analysis. Surgery Today. 51(5). 659–668. 13 indexed citations
7.
Oshima, Yoko, Takashi Suzuki, Satoshi Yajima, et al.. (2020). Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery. Surgery Today. 50(11). 1402–1408. 16 indexed citations
8.
Shiratori, Fumiaki, Masaaki Ito, Satoshi Yajima, et al.. (2019). The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma. Esophagus. 16(3). 246–251. 7 indexed citations
9.
Suzuki, Takashi, Hideaki Shimada, Tatsuki Nanami, et al.. (2017). Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma. International Journal of Clinical Oncology. 22(3). 461–468. 10 indexed citations
10.
Nanami, Tatsuki, Takashi Suzuki, Yoko Oshima, et al.. (2017). Negative conversion of high serum p53 antibody titers in a patient with gastric cancer at 31 months after surgery. Clinical Journal of Gastroenterology. 10(4). 357–360. 5 indexed citations
11.
Suzuki, Takashi, Hideaki Shimada, Tatsuki Nanami, et al.. (2016). Hyperfibrinogenemia is associated with inflammatory mediators and poor prognosis in patients with gastric cancer. Surgery Today. 46(12). 1394–1401. 46 indexed citations
12.
Shiratori, Fumiaki, Hideaki Shimada, Satoshi Yajima, et al.. (2016). Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma. Surgery Today. 47(8). 959–965. 5 indexed citations
13.
Shimada, Hideaki, Masaaki Ito, Yoko Oshima, et al.. (2014). The correlation between plasma aprepitant concentration and antiemetic effect in Japanese gastric or esophageal cancer patients. International Journal of Clinical Oncology. 20(3). 538–542. 2 indexed citations
14.
Yajima, Satoshi, Yoko Oshima, Ken Ikeda, et al.. (2013). A Case of Esophageal Cancer Diagnosed as Myotonic Dystrophy from Postoperative Clinical Course. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 74(7). 1838–1841.
15.
Kaneko, Tomoaki, et al.. (2011). A Case of Ruptured Incisional Abdominal Wall Hernia Repaired by Components Separation Method. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 36(4). 707–712.
16.
Shiratori, Fumiaki, Satoshi Yajima, Takashi Suzuki, et al.. (2011). Two Cases of Postoperative Ileus Due to Postesophagectomy Jejunostomy. Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 36(4). 654–657.
17.
Nanami, Tatsuki, Kimihiko Funahashi, Yoko Oshima, et al.. (2009). A Case of Constrictive Ischemic Colitis in the Ascending Colon. Nihon Daicho Komonbyo Gakkai Zasshi. 62(8). 522–526.
18.
Watanabe, Masashi, Satoshi Yajima, Masaru Tsuchiya, et al.. (2009). Introducing the coaxial method of catheter port implantation for hepatic arterial infusion chemotherapy. Journal of Surgical Oncology. 99(6). 382–385. 1 indexed citations
19.
Iida, Shinya, Tomoharu Fukumori, Yoko Oshima, et al.. (1999). Compatibility of Vpu-like Activity in the Four Groups of Primate Immunodeficiency Viruses. Virus Genes. 18(2). 183–187. 10 indexed citations
20.
Fukumori, Tomoharu, et al.. (1998). Suppression of HIV-2 Replication by HIV-1gagMutants. Biochemical and Biophysical Research Communications. 248(2). 418–421. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla M. van Herpen Breakdown of academic impact, for papers by Yu Sawada Breakdown of academic impact, for papers by D. Paraïso Breakdown of academic impact, for papers by Daichi Nomoto Breakdown of academic impact, for papers by Olena Kolesnik Breakdown of academic impact, for papers by Vittorio Branchi Breakdown of academic impact, for papers by Nergiz Dağoğlu Breakdown of academic impact, for papers by Ricardo Sáinz de la Cuesta Breakdown of academic impact, for papers by An‐Cheng Shiau Breakdown of academic impact, for papers by Eric R. Manusama
Rankless by CCL
2026